when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Immunology · news · pharmadog

← back to Immunology

News · Immunology

412 stories

Jun 4, 26Scientists uncover a new hiding spot for HIVstat

Jun 3, 26Legend surges on early data for ‘in vivo’ lymphoma cell therapybiopharma dive

Jun 2, 26STAT+: Radiopharmaceutical shows promise in post-Pluvicto settingstat

Jun 2, 26AbiVax falls as safety worries cloud ‘landmark’ immune drug resultsbiopharma dive

Jun 1, 26RallyBio tries again for reverse merger, this time with Avenzobiopharma dive

Jun 1, 26Agios licenses Oscotec drug; CEPI funds three potential Ebola vaccinesendpoints

Jun 1, 26Opinion: What should hospitals do when patients demand unvaccinated donor blood?stat

Jun 1, 262026 Orphan Drugs Report: A safe(r) passage amid stormy waters?biopharma dive

May 31, 26Ultra-low doses could bring costly cancer treatments to more patients in poorer countriesstat

May 29, 26Replimune takes third swing at cancer drug approval following ‘productive’ FDA talksbiopharma dive

May 29, 26Allogene CEO to step down; Agios drug fails key testbiopharma dive

May 29, 26Which vaccines will curb the Ebola outbreak? WHO debatesstat

May 29, 26STAT+: The woman behind the world’s biggest longevity competitionstat

May 28, 26GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’biopharma dive

May 19, 26A migraine drugmaker heads to the public markets through reverse mergerbiopharma dive

May 18, 26With no approved vaccine for Ebola outbreak, experts weigh testing a long shotstat

May 16, 26Opinion: The cloudy truth about ‘blue zones’stat

May 15, 26Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workersbiopharma dive

May 15, 26Andrea Pfeifer ends 23-year reign at AC Immune; Acadia's top R&D exec announces retirementendpoints

May 14, 26AVB-001 Encapsulated IL-2 Cell Therapy Shows Safety and Immune Activity in Platinum-Resistant HGSOConclive

May 14, 26Create Medicines raises $122M to bolster in vivo CAR-T therapiesbiopharma dive

May 14, 26STAT+: BeOne wins FDA approval in lymphoma racestat

May 14, 26With new data, Regenxbio to seek FDA approval of Duchenne gene therapybiopharma dive

May 14, 26Planned HERIZON-GEA-01 Analyses and the Doublet-vs-Triplet Questiononclive

May 14, 26STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 millionstat

May 13, 26Dr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical Practiceonclive

May 13, 26FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AMLonclive

May 13, 26FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphomaonclive

May 13, 26Dr Dinardo on the FDA Approval of Decitabine/Cedazuridine Plus Venetoclax in AMLonclive

May 13, 26Future Directions in Metastatic Castration-Resistant Prostate Canceronclive

← prevpage 9 of 14next →